Daniel J. Starks, Director at ABBOTT LABORATORIES (ABT), sold 96,548 shares at $111.75 ($10.7M) on 2023-05-02, disclosed to the SEC on 2023-05-02.
Open-market sale of $10.7M ABT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.97 | 46,548 | $5.2M | 48.2% |
| 2 | $110.97 | 46,548 | $5.2M | 48.2% |
| 3 | $111.75 | 3,452 | $386K | 3.6% |
| Total | $111.00 avg | 96,548 | $10.7M | 100% |
| Filing → |
| ABT | SELL | 2023-10-30 | $9.4M | — | Filing → |
| ABT | SELL | 2023-07-28 | $11.4M | — | Filing → |
| ABT | SELL | 2022-10-31 | $9.7M | — | Filing → |